Clinical trial
Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer
NCT00264602 · Dana-Farber Cancer Institute, Other · Active, not recruiting
Key facts
| NCT number | NCT00264602 |
|---|---|
| Title | Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer |
| Official title | Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital Beth Israel Deaconess Medical Center Massachusetts General Hospital |
| Status | Active, not recruiting |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | Near Infrared Imaging |
| Enrollment | 57 |
| Start date | Feb 18, 2009 |
| Primary completion | Sep 1, 2017 |
| Completion | Dec 1, 2029 |
| First posted | Dec 13, 2005 |
| Last update posted | Nov 10, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: